Superworth

Pediatrix Medical price to free cash flow MD

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026
10.4×
10-year median
9.3×
Against its 10-year history
60th
percentile: 0 is its lowest day, 100 its highest
10-year range
2.5× to 66.2×
Peer median
15.4×

Pediatrix Medical's price to free cash flow is 10.4× as of Oct 23, 2026.

That is above its ten-year median of 9.3×, close to the middle of its last ten years.

Over that time it ranged from 2.5× in Mar 2020 to 66.2× in Jul 2022.

The median for 10 hospital and care facility stocks of a similar size is 15.4×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far10.4×6.2×10.4×
20256.9×5.3×10.7×
202410.1×5.7×11.8×
20235.9×5.5×15.2×
202213.9×13.8×66.2×
202122.1×6.3×28.3×
20206.7×2.5×7.6×
20197.4×6.0×13.4×
20189.7×9.2×12.7×
201712.4×9.8×17.4×
201616.4×14.6×19.8×
201516.2×15.9×19.5×
201418.2×14.2×18.3×
201315.0×13.6×16.3×
201213.3×12.3×15.7×
201115.0×12.2×15.1×

Against its peers

Companies in Medical - Care Facilities nearest Pediatrix Medical's size, closest first, today.

CompanyPrice to free cash flow
MDPediatrix Medical10.4×
ADUSAddus HomeCare14.7×
PGNYProgyny12.5×
PRVAPrivia Healthn/m
AVAHAveanna Healthcare18.4×
HCSGHealthcare Services11.7×
ARDTArdent Health5.7×
NHCNational Healthcare25.2×
PNTGPennant42.2×
USPHU S Physical Therapy20.6×
OPCHOption Care Health15.4×
Peer median15.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Pediatrix Medical

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.